Mupirocina Galenicumderma (Mupirocin)

Mupirocin is a topical antibacterial used to treat bacterial skin infections.

• Impetigo: reduces bacterial load and promotes healing of superficial skin lesions.
• Secondary bacterial skin infections: eradicates pathogenic bacteria and limits spread.
• Folliculitis: eliminates Staphylococcus aureus involvement in hair‑follicle inflammation.
• Erysipelas: controls streptococcal infection of the dermis, reducing redness and swelling.

• Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, an enzyme essential for protein synthesis. By blocking the attachment of isoleucine to its tRNA, the drug prevents the formation of new proteins, leading to bacterial growth arrest and cell death. This mechanism is selective for bacterial cells, providing targeted antibacterial activity on the skin surface.

Mupirocin is generally well tolerated when applied to the skin, but local reactions can occur.

Common Side Effects

• Itching: mild to moderate pruritus at the application site.
• Burning sensation: transient warmth or stinging.
• Redness: localized erythema.
• Dry skin: occasional flaking or scaling.
• Mild pain: brief discomfort during application.
• Rash: non‑specific skin eruption.

Serious or Rare Side Effects

• Allergic reaction: hives, swelling, or anaphylaxis.
• Contact dermatitis: severe inflammation and blistering.
• Skin ulceration: breakdown of skin integrity.
• Severe swelling: edema extending beyond the treated area.
• Systemic infection: rare systemic absorption leading to infection elsewhere.
• Necrotizing fasciitis: extremely rare, rapidly progressing tissue death.

Before using Mupirocina Galenicumderma, consider the following safety measures.

• External use only: do not apply to eyes, ears, or mucous membranes.
• Limited surface area: avoid covering large body areas unless directed by a clinician.
• Hypersensitivity: discontinue if known allergy to mupirocin or other topical antibiotics.
• Monitor infection: seek medical advice if lesions worsen or fail to improve within the expected timeframe.
• Storage: keep at room temperature: store in the original container, protect from moisture and direct sunlight.

Mupirocin may interact with other topical agents or systemic medications.

Major Interactions (Avoid)

• Other topical antibiotics (e.g., bacitracin, neomycin): increased risk of contact dermatitis.
• Systemic aminoglycosides: potential additive nephrotoxicity, though rare with topical use.

Moderate Interactions (Monitor Closely)

• Topical corticosteroids: may mask signs of infection.
• Antifungal creams: could reduce antibacterial efficacy.
• Silver‑containing dressings: may interfere with drug absorption.
• Occlusive bandages: can enhance systemic absorption, increasing risk of side effects.
• Immunosuppressive therapy: heightened susceptibility to secondary infections.